PharmacovigilanceOfficial
AIFA closes monitoring registry for XALKORI (AIFA)
🇮🇹 AIFA · Thu 22 Oct 2026
AIFA announces that, effective 22/10/2026, monitoring will end for the AIFA XALKORI (crizotinib) registry in relation to one specific therapeutic indication, meaning prescribers/pharmacies will no longer need to register patients under that indication through this monitoring tool.
Summary written by VigiEye from the official notice. AI-assisted; check the source before acting.
More Pharmacovigilance
All →
PharmacovigilanceOfficialMedline details repair and replace programme for recalled beds, rails, mattresses and accessories
🇺🇸 FDA MedWatch · Fri 13 Nov 2026
PharmacovigilanceOfficialPRAC publishes final EU-language translations of phenobarbital product information in targeted signal procedure
🇪🇺 EMA · PRAC · Fri 13 Nov 2026
PharmacovigilanceOfficialEMA page on veterinary signal management details phenobarbital review and updated MAH templates
🇪🇺 EMA · PRAC · Fri 13 Nov 2026
PharmacovigilanceOfficialEMA publishes draft veterinary PV guideline listing medically important VeDDRA terms
🇪🇺 EMA · Fri 13 Nov 2026
PharmacovigilanceOfficialEMA opens consultation on medically important VeDDRA terms list for veterinary pharmacovigilance
🇪🇺 EMA · Fri 13 Nov 2026
PharmacovigilanceOfficialFTC sues to block Covetrus's $3.5bn acquisition of veterinary distributor MWI
🇺🇸 FTC · Fri 13 Nov 2026